Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results

Blaine Heric, Bruce W. Lytle, Dave P. Miller, Eliot Rosenkranz, Harry M. Level, Delos M. Cosgrove

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

From 1975 through 1993, 178 patients underwent surgical management of hypertrophic obstructive cardiomyopathy. Operations included isolated septa myectomy (n=95), septal myectomy and coronary artery bypass grafting (n=41), septal myectomy plus a valve procedure (n=25), septal myectomy, valve procedure, and coronary artery bypass grafting (n=14), and mitral valve replacement without septal myectomy (n=3). Recent myectomy results were monitored with transesophageal echocardiography. After initial myectomy, 32 patients (20%) underwent a second pump run for more extensive myectomy only (n=22), mitral valve replacement only (n=5), or both (n=2). In-hospital mortality was 6% (n=11) and 4% (n=6) for patients undergoing septal myectomy or septal myectomy plus coronary artery bypass grafting, respectively. Heart block occurred in 17 patients (10%). Left ventricular outflow tract systolic gradients decreased from a mean of 93 mm Hg to 21 mm Hg after myectomy. Late survival was 86% and 70% at 5 and 10 postoperative years, respectively, and 93% and 79% for patients undergoing septal myectomy alone or septal myectomy plus coronary artery bypass grafting, respectively. Only 3 of 131 in-hospital survivors of septal myectomy or septal myectomy plus coronary artery bypass grafting died late cardiac deaths, for a yearly mortality of 0.6%. However, the 5-year late survival of patients undergoing valve operation plus septal myectomy was 51%, and multivariate testing confirmed the adverse influence on late survival (p=0.008), as well as adverse influences of increasing age (p=0.016) and return to cardiopulmonary bypass for mitral valve replacement (p=0.038). At follow-up 136 patients (94%) had New York Heart Association class I or II symptoms. For patients with hypertrophic obstructive cardiomyopathy, septal myectomy alone or in combination with coronary artery bypass grafting produces effective symptom relief, excellent long-term survival, and a low risk of late cardiac death.

Original languageEnglish
Pages (from-to)195-208
Number of pages14
JournalThe Journal of thoracic and cardiovascular surgery
Volume110
Issue number1
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Hypertrophic Cardiomyopathy
Coronary Artery Bypass
Mitral Valve
Survival
Heart Block
Transesophageal Echocardiography
Hospital Mortality
Cardiopulmonary Bypass
Survivors
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results. / Heric, Blaine; Lytle, Bruce W.; Miller, Dave P.; Rosenkranz, Eliot; Level, Harry M.; Cosgrove, Delos M.

In: The Journal of thoracic and cardiovascular surgery, Vol. 110, No. 1, 01.01.1995, p. 195-208.

Research output: Contribution to journalArticle

Heric, Blaine ; Lytle, Bruce W. ; Miller, Dave P. ; Rosenkranz, Eliot ; Level, Harry M. ; Cosgrove, Delos M. / Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results. In: The Journal of thoracic and cardiovascular surgery. 1995 ; Vol. 110, No. 1. pp. 195-208.
@article{959fd3f6a8ea46b881d5391f0fb13e80,
title = "Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results",
abstract = "From 1975 through 1993, 178 patients underwent surgical management of hypertrophic obstructive cardiomyopathy. Operations included isolated septa myectomy (n=95), septal myectomy and coronary artery bypass grafting (n=41), septal myectomy plus a valve procedure (n=25), septal myectomy, valve procedure, and coronary artery bypass grafting (n=14), and mitral valve replacement without septal myectomy (n=3). Recent myectomy results were monitored with transesophageal echocardiography. After initial myectomy, 32 patients (20{\%}) underwent a second pump run for more extensive myectomy only (n=22), mitral valve replacement only (n=5), or both (n=2). In-hospital mortality was 6{\%} (n=11) and 4{\%} (n=6) for patients undergoing septal myectomy or septal myectomy plus coronary artery bypass grafting, respectively. Heart block occurred in 17 patients (10{\%}). Left ventricular outflow tract systolic gradients decreased from a mean of 93 mm Hg to 21 mm Hg after myectomy. Late survival was 86{\%} and 70{\%} at 5 and 10 postoperative years, respectively, and 93{\%} and 79{\%} for patients undergoing septal myectomy alone or septal myectomy plus coronary artery bypass grafting, respectively. Only 3 of 131 in-hospital survivors of septal myectomy or septal myectomy plus coronary artery bypass grafting died late cardiac deaths, for a yearly mortality of 0.6{\%}. However, the 5-year late survival of patients undergoing valve operation plus septal myectomy was 51{\%}, and multivariate testing confirmed the adverse influence on late survival (p=0.008), as well as adverse influences of increasing age (p=0.016) and return to cardiopulmonary bypass for mitral valve replacement (p=0.038). At follow-up 136 patients (94{\%}) had New York Heart Association class I or II symptoms. For patients with hypertrophic obstructive cardiomyopathy, septal myectomy alone or in combination with coronary artery bypass grafting produces effective symptom relief, excellent long-term survival, and a low risk of late cardiac death.",
author = "Blaine Heric and Lytle, {Bruce W.} and Miller, {Dave P.} and Eliot Rosenkranz and Level, {Harry M.} and Cosgrove, {Delos M.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/S0022-5223(05)80026-1",
language = "English",
volume = "110",
pages = "195--208",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results

AU - Heric, Blaine

AU - Lytle, Bruce W.

AU - Miller, Dave P.

AU - Rosenkranz, Eliot

AU - Level, Harry M.

AU - Cosgrove, Delos M.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - From 1975 through 1993, 178 patients underwent surgical management of hypertrophic obstructive cardiomyopathy. Operations included isolated septa myectomy (n=95), septal myectomy and coronary artery bypass grafting (n=41), septal myectomy plus a valve procedure (n=25), septal myectomy, valve procedure, and coronary artery bypass grafting (n=14), and mitral valve replacement without septal myectomy (n=3). Recent myectomy results were monitored with transesophageal echocardiography. After initial myectomy, 32 patients (20%) underwent a second pump run for more extensive myectomy only (n=22), mitral valve replacement only (n=5), or both (n=2). In-hospital mortality was 6% (n=11) and 4% (n=6) for patients undergoing septal myectomy or septal myectomy plus coronary artery bypass grafting, respectively. Heart block occurred in 17 patients (10%). Left ventricular outflow tract systolic gradients decreased from a mean of 93 mm Hg to 21 mm Hg after myectomy. Late survival was 86% and 70% at 5 and 10 postoperative years, respectively, and 93% and 79% for patients undergoing septal myectomy alone or septal myectomy plus coronary artery bypass grafting, respectively. Only 3 of 131 in-hospital survivors of septal myectomy or septal myectomy plus coronary artery bypass grafting died late cardiac deaths, for a yearly mortality of 0.6%. However, the 5-year late survival of patients undergoing valve operation plus septal myectomy was 51%, and multivariate testing confirmed the adverse influence on late survival (p=0.008), as well as adverse influences of increasing age (p=0.016) and return to cardiopulmonary bypass for mitral valve replacement (p=0.038). At follow-up 136 patients (94%) had New York Heart Association class I or II symptoms. For patients with hypertrophic obstructive cardiomyopathy, septal myectomy alone or in combination with coronary artery bypass grafting produces effective symptom relief, excellent long-term survival, and a low risk of late cardiac death.

AB - From 1975 through 1993, 178 patients underwent surgical management of hypertrophic obstructive cardiomyopathy. Operations included isolated septa myectomy (n=95), septal myectomy and coronary artery bypass grafting (n=41), septal myectomy plus a valve procedure (n=25), septal myectomy, valve procedure, and coronary artery bypass grafting (n=14), and mitral valve replacement without septal myectomy (n=3). Recent myectomy results were monitored with transesophageal echocardiography. After initial myectomy, 32 patients (20%) underwent a second pump run for more extensive myectomy only (n=22), mitral valve replacement only (n=5), or both (n=2). In-hospital mortality was 6% (n=11) and 4% (n=6) for patients undergoing septal myectomy or septal myectomy plus coronary artery bypass grafting, respectively. Heart block occurred in 17 patients (10%). Left ventricular outflow tract systolic gradients decreased from a mean of 93 mm Hg to 21 mm Hg after myectomy. Late survival was 86% and 70% at 5 and 10 postoperative years, respectively, and 93% and 79% for patients undergoing septal myectomy alone or septal myectomy plus coronary artery bypass grafting, respectively. Only 3 of 131 in-hospital survivors of septal myectomy or septal myectomy plus coronary artery bypass grafting died late cardiac deaths, for a yearly mortality of 0.6%. However, the 5-year late survival of patients undergoing valve operation plus septal myectomy was 51%, and multivariate testing confirmed the adverse influence on late survival (p=0.008), as well as adverse influences of increasing age (p=0.016) and return to cardiopulmonary bypass for mitral valve replacement (p=0.038). At follow-up 136 patients (94%) had New York Heart Association class I or II symptoms. For patients with hypertrophic obstructive cardiomyopathy, septal myectomy alone or in combination with coronary artery bypass grafting produces effective symptom relief, excellent long-term survival, and a low risk of late cardiac death.

UR - http://www.scopus.com/inward/record.url?scp=0029070957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029070957&partnerID=8YFLogxK

U2 - 10.1016/S0022-5223(05)80026-1

DO - 10.1016/S0022-5223(05)80026-1

M3 - Article

C2 - 7609544

AN - SCOPUS:0029070957

VL - 110

SP - 195

EP - 208

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 1

ER -